Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
6,173
Funds Holding Change
+54
Funds Holding Growth
+0.9%
Value
$2.17T
Holding in Top 10
940
Top 10 Change
-121
Top 10 Growth
-11%
Value Growth
+9%
New
267
Increased
2,786
Reduced
2,702
Closed
139
Capital Inflow
$107B
Capital Outflow
$59.1B
Net Capital Flow
+$47.9B
Capital Flow Change
-$246B
Calls
$27B
Puts
$25.2B
Net Calls
+$1.78B
Put/Call Ratio
0.93